Sharepoint Solutions
PRODUCTS
-
We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
Pharmaceutical and biotechnology manufacturers must ensure the quality of materials - from incoming raw material through finished product.
-
QPF4209 is a Wi-Fi 7 front end module that integrates a PA, SP2T switch, and LNA. It offers optimized performance, low power consumption, and a compact design.
-
By combining purpose-built polymers and lipids, animal-origin-free reagents seamlessly blend into the AAV manufacturing process during transfection to dramatically increase AAV titers.
WHITE PAPERS AND CASE STUDIES
-
Design Testing Strategies To Develop A Drug-Device Combination Product
Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.
-
Streamline Recruitment With Confidence
Transform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
-
Biostatistics And Programming — More Than Just Clinical Trials
See how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
AOC GMP Manufacture For A FIH Study
Successful development of AOCs for FIH studies requires robust GMP processes and efficient scale-up. A key step is careful management of a multi-day conjugation process with vital in-process checks.
-
Relieving The Strain Of Publishing During Regulatory Registration
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
How To Avoid Sticking And Picking In The Tableting Industry
Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.
-
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia
Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
NEWS
-
Latvian Scientists Create A Tool For More Efficient Public Procurement Evaluation1/10/2026
Much of public procurement evaluation consists of manual work by experts and specialists. This is time-consuming, since it involves comparing extensive documentation, evaluating compliance with regulatory requirements—like whether there are competition-restricting criteria—and other factors.
-
Klarna Announces Partnership With OnePay To Exclusively Power Installment Loans At Walmart In The U.S3/17/2025
Klarna, the AI-powered payments and commerce network, today announced that it will be partnering with OnePay, a leading consumer finance app, to exclusively offer installment loans for purchases at Walmart in the United States.
-
H2APEX And Copenhagen Infrastructure Partners Enter Into Strategic Partnership For Pioneering Hydrogen Project In Lubmin8/5/2025
H2APEX Group SCA announces that Copenhagen Infrastructure Partners (CIP) – one of the world’s leading investment companies in energy infrastructure investments – has acquired a majority stake of 70% in the first phase of H2APEX’s IPCEI-funded hydrogen project in Lubmin through its Energy Transition Fund (CI ETF I) as a strategic investor.
-
Safeguarding Citrus: International Collaboration Between Australia And Indonesia, Targets Huánglóngbìng Threat6/25/2025
NSW Department of Primary Industries and Regional Development (NSW DPIRD) has reaffirmed its commitment to protecting Australia’s citrus industry through international collaboration against huánglóngbìng (HLB), also known as citrus greening disease.
-
Higgins, Timmons Introduce Legislation To Repeal EPA Rule On Chemical Manufacturing3/11/2025
Congressman Clay Higgins (R-LA) and Congressman William Timmons (R-SC) introduced legislation to repeal the U.S. Environmental Protection Agency’s (EPA) final procedural rule for new chemical reviews under the Toxic Substances Control Act (TSCA).